DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 245 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2024. The put-call ratio across all filers is 2.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $5,250,888 | +95.6% | 375,600 | +106.6% | 0.01% | -11.1% |
| Q3 2023 | $2,685,186 | +14.3% | 181,800 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $2,348,856 | +29.2% | 181,800 | -1.9% | 0.01% | +33.3% |
| Q1 2023 | $1,817,793 | +45.5% | 185,300 | +57.8% | 0.01% | +20.0% |
| Q4 2022 | $1,249,136 | +101.8% | 117,400 | +98.3% | 0.01% | +400.0% |
| Q3 2022 | $619,024 | -12.1% | 59,200 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $704,520 | +80.6% | 56,000 | +175.9% | 0.00% | 0.0% |
| Q3 2021 | $390,000 | +41.3% | 20,300 | -34.9% | 0.00% | 0.0% |
| Q2 2020 | $276,000 | -88.5% | 31,200 | -94.8% | 0.00% | -80.0% |
| Q2 2019 | $2,398,000 | +7.6% | 601,000 | +160.3% | 0.01% | -50.0% |
| Q2 2017 | $2,228,000 | +77.2% | 230,900 | +9.3% | 0.01% | +66.7% |
| Q1 2017 | $1,257,000 | +50.7% | 211,200 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $834,000 | -71.2% | 211,200 | -23.5% | 0.00% | -69.2% |
| Q3 2016 | $2,897,000 | -28.0% | 276,212 | +0.0% | 0.01% | -27.8% |
| Q2 2016 | $4,026,000 | -27.2% | 276,120 | -3.9% | 0.02% | -28.0% |
| Q1 2016 | $5,530,000 | +8.3% | 287,427 | +36.0% | 0.02% | +13.6% |
| Q4 2015 | $5,106,000 | -3.6% | 211,351 | -2.1% | 0.02% | 0.0% |
| Q3 2015 | $5,296,000 | – | 215,794 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |